Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12329909
Airway management systems for pulmonary disorder treatment
granted -
US 12329772
Methods and compositions for administration of iron
granted -
US 12329744
Methods of preparing extrudates
granted -
US 12329829
Kit for radiolabelling with 68GA comprising a metal inhibitor
granted -
US 12331105
Broadly neutralizing antibodies against HIV
granted -
US 12329882
Aligned hydrogel tubes for tissue repair and regeneration
granted -
US 12331124
ALK2 antibodies and methods of use thereof
granted -
US 12331110
Monoclonal antibodies against endotrophin and the use thereof
granted -
US 12331058
SHP2 and CDK4/6 dual-target inhibitory compound and pharmaceutical composition containing the same
granted -
US 12331107
Methods of treating pneumonia or respiratory failure associated with COVID-19 by administering an anti-LIGHT antibody
granted -
US 12331109
Antigen binding molecule formats
granted -
US 12329805
Dosage forms of tissue kallikrein 1
granted -
US 12329825
Muscle targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of use thereof to induce exon skipping of exon 44 of dystrophin in a subject
granted -
US 12331307
Modified immunization vectors
granted -
US 12331127
Therapeutic uses of anti-GITR antibodies
granted -
US 12331056
SHP2 phosphatase inhibitors and methods of use thereof
granted -
US 12331078
Stabilizing mutants of prefusion SARS-CoV-2 (COVID-19) spike protein and improved yeast surface display engineering platform for the same
granted -
US 12329776
Treatment methods for ALS patients
granted -
US 12331126
OX40-binding polypeptides and uses thereof
granted -
US 12331036
Heterocyclic RIP1 kinase inhibitors
granted -
US 12331057
Modulators of alpha-1 antitrypsin
granted -
US 12329748
Anhydrous compositions of mTOR inhibitors and methods of use
granted -
US 12329747
Use of lipophilic beta-lactam antibiotics and carboxylate esters for the treatment of bacterial infections within citrus and other plant species
granted -
US 12331079
Oncolytic virus platform to treat cancers with myxoma virus
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.